The Percept™ family of neurostimulators deliver personalized, upgradable therapy, powered by BrainSense™ technology. BrainSense™ technology† uses brain signals to provide a window into a patient's condition, in real time, over time.
The Percept™ PC and Percept™ RC neurostimulators feature BrainSense™ technology, designed to capture brain signals (local field potentials, or LFPs) using the implanted deep brain stimulation (DBS) lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, at the time symptoms occurred.
You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects to deliver personalized, data-driven treatment and adjust as patient needs evolve.
Medtronic’s DBS therapy is approved for 4 indications: Parkinson’s disease, essential tremor and epilepsy. Indications vary by product, refer to product labeling for details.
BrainSense™ technology captures brain signals (local field potentials or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic. Clinicians can also correlate these brain signals with stimulation and patient-captured events such as medication, symptoms, or side effects.
The Percept™ family with BrainSense™ technology is the most complete DBS system with sensing and directionality so you can access data-driven insights to tailor therapy with confidence.
BrainSense™ technology uses brain signals to provide clinicians with objective data to understand the impact of treatment decisions such as medication or stimulation changes.
The tablet images below are associated with Parkinson‘s disease.
† The sensing feature of the Percept™ PC and Percept™ RC system is intended for use in patients receiving DBS where chronically recorded bioelectric data may provide useful, objective information regarding patient clinical status. The majority of patients with Parkinson’s disease have an identifiable signal. Signal may not be present or measurable in patients treated for essential tremor, dystonia or epilepsy.
You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic Canada does not review or control the content on the other website, and is not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site not be licensed for sale in Canada.
